Skip Navigation Menu
Government of Ontario Central Web Site Ontario Ministry of Health and Long-Term Care
Return to Home Page Government of Ontario Central Web Site Contact us for questions and comments Site map Version française de cette site web
Information Channels Public Information Health Care Providers News Media Text Only Version
Index Health Care Provider Section
Formulary Downloads
O P D P   H O M E
Plan to Reform Ontario's Drug System
Legislation
Formulary
Publicly Funded Drug Programs
Executive Officer Communications
Drug Submissions
How Drugs Are Approved
Councils
Drug Innovation Fund
· Terms of Reference
MedsCheck
Glossary
Forms/Guidelines
FAQs
Resources
Contact Us

Drug Innovation Fund

Joint Academic and Relevance Review Panel
Terms of Reference

3.  TERMS AND PROCEDURES

  • Prior to each scheduled meeting of the full Panel, Panel members will be required to dedicate time to evaluate and score all LOIs and/or full research applications.
  • Two reviewers - one academic and one relevance – will be assigned to each LOI and research application as lead presenters. Each lead presenter will present their reviews of an LOI/full application to the entire Panel, and both will have equal responsibility in leading Panel discussions as well as perform any extra duties associated with the review of that application (i.e., summarize details of complicated discussions/recommendations, etc.).

Conflict of Interest :

  • A Joint Academic and Relevance Review Panel member has a conflict of interest with an application if he or she is from the same department as the applicant, has worked with the applicant within the past 5 years, or is a personal friend.
  • Members having a conflict of interest with an applicant do not receive any assessments of the application, and should not be present during any discussions pertaining to the applicant. Members from the same institution as an applicant, but not in conflict, may remain in the room but do not participate in the review.

Freedom of Information and Protection of Privacy :

  • Under the terms of the Freedom of Information and Protection of Privacy Act (1987), the information contained in an application to the Ontario Public Drug Programs, including written evaluations and personal information pertaining to the applicant are confidential.
  • Panel members and external reviewers are expected to maintain the confidentiality of the material at all times, including refraining from any secondary use of the information.
  • Applicants may access their personal information freely. However, the identity of reviewers and appraisers will be held in confidence.
  • Personal information, for example, the Panel's recommendation on an application, will continue to be available only to the individual concerned.

See also :

For more information
INFOline
Tel : 1-866-532-3161
(Toll-free in Ontario only)
TTY 1-800-387-5559
Hours of operation: 8:30am - 5:00pm
Go to top of page
|  home  |  central site  |  contact us  |  site map  |  français  |

This site maintained by the government of Ontario, Canada.